ArticleNature communications2021

A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.

Shoichi Iriguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.